You are here

addiction

Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At

Forbes

Thu, 04/18/24 - 10:25 pm

Top U.S. addiction researcher calls GLP-1 data for addiction ‘very, very exciting’

Stat

Thu, 03/21/24 - 06:43 pm

FDA calls for treatments for meth and cocaine addiction

Stat

Wed, 10/4/23 - 11:25 pm

drug development

cocaine addiction

3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer

Motley Fool

Thu, 08/24/23 - 09:50 pm

cardiovascular disease

Ozempic Sales Are Soaring -- Here's Why They Could Go Even Higher

Motley Fool

Thu, 07/6/23 - 11:17 am

In new editorial, FDA's Califf says biomedical field should prioritize chronic illness, addiction

Fierce Biotech

Thu, 08/25/22 - 07:45 pm

chronic disease

New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer's, addiction and more

Fierce Biotech

Sat, 09/7/19 - 06:28 pm

psychedelic drugs

drug development

Alzheimer's disease

New on the streets: Gabapentin, a drug for nerve pain, and a new target of abuse

Stat

Thu, 07/6/17 - 02:37 pm

Gilead offloads a PhII-ready addiction therapy to an upstart which knows this drug well

Endpoints

Sat, 02/18/17 - 02:21 pm

Gilead Sciences

CV Therapeutics

Anti-addiction groups call for new FDA chief

Yahoo/AP

Wed, 09/24/14 - 09:49 am

Margaret Hamburg

Titan’s Probuphine Dosing May Need Review, FDA Staff Says

Bloomberg

Tue, 03/19/13 - 11:17 am

Titan Pharmaceuticals

Titan Pharmaceuticals Provides Additional Details on Confirmatory Phase 3 Study of Probuphine

Yahoo/MarketWire

Sat, 06/18/11 - 10:05 am

FDA panel urges wider use for Alkermes drug

Reuters

Fri, 09/17/10 - 11:55 am

advisory panels

Aoxing Pharmaceutical Company and Phoenix PharmaLabs, Inc. Announce Strategic Alliance to Co-Develop a Novel Class of Molecules in Pain and Drug Addiction Therapeutics

Pipeline Review

Sat, 06/5/10 - 11:57 am

Phoenix PharmaLabs

pain management